Design of clinical trials to evaluate the efficacy of platelet transfusion: The euroSPRITE trial for components treated with helinx™ technology
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 38, 46-54
- https://doi.org/10.1016/s0037-1963(01)90123-4
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A comparison of prestorage WBC-reduced whole-blood-derived platelets and bedside-filtered whole-blood-derived platelets in autologous progenitor cell transplantTransfusion, 2000
- Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective Comparative Trial in 105 Patients With Acute Myeloid LeukemiaBlood, 1998
- The Threshold for Prophylactic Platelet Transfusions in Adults with Acute Myeloid LeukemiaNew England Journal of Medicine, 1997
- Platelet production in the Old World—and the NewTransfusion, 1996
- White cell-reduced platelet concentrates prepared by in-line filtration of platelet-rich plasmaTransfusion, 1995
- In vitro and in vivo effects of prestorage filtration of apheresis plateletsTransfusion, 1995
- The Collection of Platelets by Apheresis ProceduresTransfusion Medicine Reviews, 1994
- Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemiaThe Lancet, 1991
- Causes of Death in Acute LeukemiaJAMA, 1965
- The Quantitative Relation between Platelet Count and Hemorrhage in Patients with Acute LeukemiaNew England Journal of Medicine, 1962